lifestyle management

News

Major trial launched to explore GLP-1 benefit in dementia

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

News

England’s diabetes prevention success: patients shed weight ...

Three years after launching a forward-thinking diabetes prevention programme, NHS England yesterday hailed early signs of a very significant impact on those at-risk people taking part.

News

Datroway joins Trodelvy for frontline TNBC in the EU

AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks